Retatrutide (LY3437943) is an investigational triple hormone receptor agonist that activates: GLP-1 (glucagon-like peptide-1) receptor GIP (glucose-dependent insulinotropic polypeptide) receptor Glucagon (GCG) receptor This triple G mechanism targets multiple pathways for appetite control, insulin sensitivity, glucose regulation, and energy/fat metabolismpotentially offering greater effects than dual (GLP-1/GIP) or single agonists
Final thoughts Im going to repeat myself
The majority of gastrointestinal adverse events occurred during the titration phase of tirzepatide
As sleep deepens, recovery from training improves, morning soreness eases, and daytime energy feels steadier
Case methodology disclosed Health Canada reviewed 15 cases of suicide, self-harm and suicidal/self-harm ideation in patients using GLP-1 RAs, including 3 Canadian and 12 international reports, with 2 drawn from published literature
Clinical studies conducted using quercetin formulated with the Phytosome delivery system (Quercefit) have shown that it can enhance standard asthma management by reducing symptoms, the need for rescue medication, and oxidative stress, while maintaining higher peak expiratory flow [193]
